1. Compounded drug products that are essentially copies of a commercially available drug product under Section 503A of the Federal Food, Drug, and Cosmetic Act Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2018 Subject(s): Drug Compounding -- standardsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.United States.
